Literature DB >> 571022

Molecular weight determination of commercial heparin sodium USP and its sterile solutions.

H J Rodriguez, A J Vanderwielen.   

Abstract

A liquid chromatographic assay for the characterization of heparin sodium USP, and heparin sterile solutions was developed. The method employs size exclusion chromatography and computer-based data collection and manipulation. An examination of commercially available heparin showed only minor differences between the heparins extracted from beef lung and porcine intestinal mucosa. The molecular weight averages of the material and its sterile solutions were 9000-12,000 daltons. A correlation was observed between average molecular weight and anticoagulant activity for the heparin sodium samples examined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571022     DOI: 10.1002/jps.2600680519

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.

Authors:  J F Eidt; P Allison; S Noble; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 2.  Tools for the Quality Control of Pharmaceutical Heparin.

Authors:  Anthony Devlin; Courtney Mycroft-West; Patricia Procter; Lynsay Cooper; Scott Guimond; Marcelo Lima; Edwin Yates; Mark Skidmore
Journal:  Medicina (Kaunas)       Date:  2019-09-25       Impact factor: 2.430

3.  Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors.

Authors:  Cho Yeow Koh; Norrapat Shih; Christina Y C Yip; Aaron Wei Liang Li; Weiming Chen; Fathiah S Amran; Esther Jia En Leong; Janaki Krishnamoorthy Iyer; Grace Croft; Muhammad Ibrahim Bin Mazlan; Yen-Lin Chee; Eng-Soo Yap; Dougald M Monroe; Maureane Hoffman; Richard C Becker; Dominique P V de Kleijn; Vaishali Verma; Amita Gupta; Vijay K Chaudhary; A Mark Richards; R Manjunatha Kini; Mark Y Chan
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.